Apremilast: A novel adjuvant treatment for refractory isotretinoin-induced acne fulminans

Dermatol Ther. 2022 Aug;35(8):e15637. doi: 10.1111/dth.15637. Epub 2022 Jul 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acne Vulgaris* / chemically induced
  • Acne Vulgaris* / drug therapy
  • Adjuvants, Immunologic / adverse effects
  • Humans
  • Isotretinoin* / adverse effects
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives

Substances

  • Adjuvants, Immunologic
  • Thalidomide
  • Isotretinoin
  • apremilast